In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant staphylococcus aureus-Reference-Cited by-同舟云学术

In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant staphylococcus aureus

Published:1984-07 Issue:4 Volume:12 Page:293-295
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Graninger W.,Leitha T.,Georgopoulos A.,Havel M.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01645964.pdf

Reference13 articles.

1. Kirby, W. M. M. Pharmacokinetics of fosfomycin. Chemotherapy 23 Suppl. (1977) 141.

2. Stahl, J. P., Croise, J., Bru, J. P., Girard-Blanc, M. F., Francois, P., Gaillat, J., Micoud, M.: Fosfomycin diffusion into cerebrospinal fluid of human bacterial meningitis. Proceedings of the 13th International Congress of Chemotherapy, Vienna 1983, SS. 4.6, 8–2.

3. Vömel, W., Abshagen, U., Betzien, G., Haag, R., Hoffmann, R. Zur Humanpharmakokinetik und antibakteriellenIn vitro-Aktivität von Fosfomycin. Der Krankenhausarzt 54 (1981) 771–790.

4. Haag, R., Vömel, W. Einflüsse auf die Aktivität von Fosfomycinin vitro. Immun. Infekt. 7 (1979) 202–209.

5. Gobernado, M., Santos, M., Diosdado, N., Perez, F. The evolution of the sensitivity to fosfomycin over the past 2 years. Chemotherapy 23 Suppl. (1977) 99–103.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PREPARATION AND CHARACTERIZATIONS OF ANTIBIOTIC IMPREGNATED MICROPOROUS NANO-HYDROXYAPATITE FOR OSTEOMYELITIS TREATMENT;Biomedical Engineering: Applications, Basis and Communications;2014-03-17

2. Antimicrobial Performance and Cytotoxicity of Antibiotics Impregnated Hydroxyapatite for Osteomyelitis Treatment;Advanced Materials Research;2012-04

3. New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus;Clinical Microbiology and Infection;2009-12

4. Fosfomycin: an old, new friend?;European Journal of Clinical Microbiology & Infectious Diseases;2009-11-14

5. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies;Expert Opinion on Investigational Drugs;2009-06-24